Redox-responsive nano-carriers as tumor-targeted drug delivery systems. 2018

Ali Raza, and Uzma Hayat, and Tahir Rasheed, and Muhammad Bilal, and Hafiz M N Iqbal
School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.

With ever increasing scientific knowledge and awareness, research is underway around the globe to design new types of stimuli (external/internal) responsive nano-carriers for biotechnological applications at large and biomedical/pharmaceutical in particular. Based on literature evidence, stimuli-responsive carriers have been classified into four major categories, i.e. (1) physical, (2) chemical, (3) biological, and (4) dual (combination of any of the first three classes). Among various types, redox-responsive nano-carriers are of supreme interests and discussed here in this review. The difference in redox potential in tumor and normal tissue is considered as a potential target for tumor targeting leading to the development of redox-responsive drug delivery systems (DDS). In this regard, a high concentration of glutathione in tumor/intracellular environment has extensively been exploited. Disulfide bonds were found as a promising tool for designing redox-responsive which tend to cleave in a reductive environment forming sulfhydryl groups. Many nano-carriers have been explored widely to control tumor growth. These systems were used against the tumor xenograft animal model and showed improved tumor targeting with tumor growth inhibition. Herein, an effort has been made to summarize various aspects from design to development of numerous types of redox-responsive DDS including liposomes, micelles, nanoparticles, nanogel and prodrug based nanomedicines. An emphasis is also given on various types of nano-carriers with special reference to the tumor-targeted drug delivery applications. Also, dual responsive nano-carriers (in addition to redox-responsive) have also been briefly discussed. Towards the end of the chapter, the information is also given on their future perspectives.

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008823 Micelles Particles consisting of aggregates of molecules held loosely together by secondary bonds. The surface of micelles are usually comprised of amphiphatic compounds that are oriented in a way that minimizes the energy of interaction between the micelle and its environment. Liquids that contain large numbers of suspended micelles are referred to as EMULSIONS. Micelle
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D011094 Polyethyleneimine Strongly cationic polymer that binds to certain proteins; used as a marker in immunology, to precipitate and purify enzymes and lipids. Synonyms: aziridine polymer; Epamine; Epomine; ethylenimine polymer; Montrek; PEI; Polymin(e). Polyaziridine,Polyethylenimine,Polyaziridines,Polyethyleneimines,Polyethylenimines
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000080385 Nanogels Three-dimensional biocompatible materials formed by cross-linking a hydrophilic polymeric component (e.g., HYDROGELS). They are typically spherical particles in a size range of 20-250 nm when used for drug delivery applications. Nanocomposite Gel,Nanocomposite Gels,Nanocomposite Hydrogel,Nanocomposite Hydrogels,Gel, Nanocomposite,Hydrogel, Nanocomposite
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Ali Raza, and Uzma Hayat, and Tahir Rasheed, and Muhammad Bilal, and Hafiz M N Iqbal
February 2020, International journal of pharmaceutics,
Ali Raza, and Uzma Hayat, and Tahir Rasheed, and Muhammad Bilal, and Hafiz M N Iqbal
September 2018, Journal of nanobiotechnology,
Ali Raza, and Uzma Hayat, and Tahir Rasheed, and Muhammad Bilal, and Hafiz M N Iqbal
July 2005, Gan to kagaku ryoho. Cancer & chemotherapy,
Ali Raza, and Uzma Hayat, and Tahir Rasheed, and Muhammad Bilal, and Hafiz M N Iqbal
June 2017, ACS applied materials & interfaces,
Ali Raza, and Uzma Hayat, and Tahir Rasheed, and Muhammad Bilal, and Hafiz M N Iqbal
June 2012, Expert opinion on drug delivery,
Ali Raza, and Uzma Hayat, and Tahir Rasheed, and Muhammad Bilal, and Hafiz M N Iqbal
December 2020, Journal of controlled release : official journal of the Controlled Release Society,
Ali Raza, and Uzma Hayat, and Tahir Rasheed, and Muhammad Bilal, and Hafiz M N Iqbal
May 2016, Journal of materials chemistry. B,
Ali Raza, and Uzma Hayat, and Tahir Rasheed, and Muhammad Bilal, and Hafiz M N Iqbal
April 2020, International journal of pharmaceutics,
Ali Raza, and Uzma Hayat, and Tahir Rasheed, and Muhammad Bilal, and Hafiz M N Iqbal
June 2018, Journal of biomedical nanotechnology,
Ali Raza, and Uzma Hayat, and Tahir Rasheed, and Muhammad Bilal, and Hafiz M N Iqbal
December 2022, Drug delivery,
Copied contents to your clipboard!